Clinical outcomes for Clostridioides difficile associated diarrhea in inflammatory bowel disease patients versus non-IBD population: A retrospective cohort study. Issue 6 (10th February 2023)

• Record Type: Journal Article
• Authors: Drozdinsky, Genady; Atamna, Alaa; Banai, Hagar; Ben-Zvi, Haim; Bishara, Jihad; Eliakim-Raz, Noa
• Is Part Of: Medicine. Volume 102:Issue 6(2023)
• Page Start: e32812
• Publication Date: 2023-02-10
• Subjects: antibiotic -- Clostridioides difficile infection (CDI) -- inflammatory bowel disease (IBD); Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000032812
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Patients with inflammatory bowel disease (IBD) have a higher incidence of Clostridioides difficile infection (CDI). Previous studies have demonstrated negative clinical outcomes in IBD patients with CDI compared to patients without CDI. The clinical presentation of CDI is indistinguishable from IBD exacerbation, thus posing a frequent clinical dilemma on the role of Clostridioides infection in the testing, diagnosis, and treatment of these patients. To compare clinical outcomes of CDI in patients with IBD to those without IBD. Retrospective cohort of adult patients admitted to Rabin Medical Center Israel between the years 2014 and 2020 with a concurrent diagnosis of IBD and CDI. Matching 1:2 was performed between the IBD patients and the non-IBD population with respect to age and sex. Sixty-seven patients with IBD and 134 patients without IBD were included in the study. The groups' median age was 40.6 (interquartile range [IQR] of 29.8–68.9), with 45.8% male and 54.2% female. The non-IBD group had a higher Charlson score with 2 (IQR 0; 5) versus 0 (IQR 0; 4) in the IBD group ( P value <.01). Patients with IBD had more exposure to systemic antibiotics, 71.1% versus 26.3% ( P value <.01). In a multivariable analysis we found no difference in 90-day mortality and rate of relapse between the 2 study groups with an odds ratio of 1.709 (95% confidence interval 0.321–9.905) and odds ratio of 0.209 (95% confidence interval 0.055–1.513) respectively. In our cohort patients with IBD who present with diarrhea and concomitant CDI have similar rates of relapse and mortality compared with patients without IBD.